HSCS Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
0
0
-100.0%
2.4K
+27.3%
1.9K
-56.3%
4.3K
Cost of Revenue
0
0
-100.0%
1.0K
+32.6%
760
-59.6%
1.9K
Gross Profit
0
0
-100.0%
1.4K
+23.8%
1.1K
-53.8%
2.5K
Operating Expenses
2.5M
+31.5%
1.9M
-7.0%
2.1M
+10.6%
1.9M
-2.5%
1.9M
R&D
476.2K
-25.4%
638.6K
-12.2%
727.0K
-27.1%
997.2K
+7.3%
929.1K
SG&A
2.1M
+59.7%
1.3M
-4.3%
1.3M
+53.5%
878.1K
-11.6%
993.8K
Operating Income
-2536405
-31.5%
-1928940
+7.0%
-2073403
-10.6%
-1874119
+2.4%
-1920399
EBITDA
-2529647
-31.6%
-1922024
+7.0%
-2066397
-10.7%
-1867008
+2.4%
-1912886
Net Income
-2750904
-38.6%
-1985208
+15.6%
-2350769
-14.4%
-2054994
+1.9%
-2094330
EPS (Basic)
$-0.85
-34.9%
$-0.63
+25.9%
$-0.85
+46.2%
$-1.58
+19.0%
$-1.95
EPS (Diluted)
$-0.85
-34.9%
$-0.63
+25.9%
$-0.85
+46.2%
$-1.58
+19.0%
$-1.95
Shares (Diluted)
3.3M
+2.9%
3.2M
+13.7%
2.8M
+113.3%
1.3M
+21.6%
1.1M
HeartSciences (HSCS) โ€” Financials